Condition
Portal Vein, Cavernous Transformation Of
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Unknown4
Clinical Trials (4)
Showing 4 of 4 trials
NCT02853526Phase 3UnknownPrimary
TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
NCT02505152Not ApplicableUnknown
Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy
NCT02505113UnknownPrimary
Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis
NCT02504034Not ApplicableUnknownPrimary
Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein
Showing all 4 trials